| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $102.1M | +8.0% |
| R&D Expense | $1.3M | +109.0% |
| SG&A Expense | $74.1M | +2.0% |
| Operating Income | -$44.3M | +20.9% |
| Interest Expense | $12.2M | +31.0% |
| Pre-tax Income | -$56.8M | -6.9% |
| Income Tax | $370K | -45.0% |
| Net Income | -$57.2M | -6.2% |
| EPS (Basic) | -$2.67 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $13.1M | -60.2% |
| Short-term Investments | $39.4M | +100.1% |
| Accounts Receivable | $14.7M | +107.9% |
| Inventory | $6.0M | — |
| Current Assets | $106.7M | +34.5% |
| Total Assets | $254.1M | +13.4% |
| Current Liabilities | $26.0M | -5.3% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$6.4M | +63.4% |
| Investing Cash Flow | -$68.3M | -349.2% |
| Financing Cash Flow | $55.7M | +91.6% |
| -567.5% |
| EPS (Diluted) | -$2.67 | -567.5% |
| Long-term Debt |
| $107.7M |
| +28.9% |
| Total Liabilities | $160.2M | +22.3% |
| Stockholders' Equity | $94.0M | +0.9% |